Press Releases in Press Releases

Feinstein Institute researcher awarded $3.5M to develop bladder cancer care program

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Professor Michael A. Diefenbach, PhD, received a five-year $3.5 million R01 grant from the National Institutes of Health’s (NIH) National Cancer Institute to develop a post-surgical care program for stage II bladder cancer patients and their caregivers. This is the first study to address the needs of bladder… read more

posted in: Press Releases

Novel therapy for uncontrolled high blood pressure studied at Northwell Health

Posted

MANHASSET, NY – Teams from Northwell Health’s Sandra Atlas Bass Heart Hospital at North Shore University Hospital and Feinstein Institute for Medical Research are the first in New York State – and among the first nationally – to treat a patient with a new implantable device for uncontrolled blood pressure as part of a recently-launched clinical… read more

posted in: Press Releases

Feinstein Institute researcher uncovers new understanding of certain psychiatric diseases

Posted

MANHASSET, NY – Research scientists from The Feinstein Institute for Medical Research and the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, NY, in conjunction with their colleagues at Rockefeller University in New York City, have developed a new understanding of how certain psychiatric diseases – those that involve uncontrollable reactions to stimuli… read more

posted in: Press Releases

Northwell Health, Feinstein Institute executives chosen to advise Sanguistat

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD, along with Northwell Health Senior Vice President, Clinical Strategy and Development, and Associate Chief Medical Officer Martin Doerfler, MD, will each play key roles in the emerging Connecticut-based biotech company Sanguistat, Inc. Announced at Sanguistat’s first board meeting this month, both… read more

posted in: Press Releases

Leading mitochondrial DNA researcher discusses causes of common complex diseases at Feinstein Institute Marsh Lecture

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research hosted a Marsh Lecture this week by Douglas C. Wallace, PhD, a renowned leader in mitochondrial DNA research and director of the Center for Mitochondrial and Epigenomic Medicine at Children’s Hospital of Philadelphia. Dr. Wallace discussed his research to determine the mitochondrial causes of common “complex” diseases. Dr…. read more

posted in: Press Releases

Elmezzi Scholar wins pediatric surgery research award

Posted

MANHASSET, NY – The Feinstein Institute for Medical Research’s Caroline Maloney, MD, received The American Pediatric Surgical Association’s (APSA) M. Judah Folkman Memorial Award for her research in identifying a drug’s potential to prevent bone tumors from spreading, a process called metastasis. Surgery is often the primary course of action to stop a cancer from growing, but… read more

posted in: Press Releases

Feinstein Institute scientist recognized for anticoagulation management practices

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Professor Alex C. Spyropoulos, MD, earned the 2018 IPRO Quality Award for championing, developing and educating health care professionals in anticoagulation management best practices. The award was presented during a ceremony at the annual meeting of the quality improvement organization IPRO. “I am honored to be recognized for my… read more

posted in: Press Releases

Latest bioelectronic medicine discoveries focus of Feinstein Institute-hosted symposium

Posted

STOCKHOLM – Leading researchers from neuroscience, molecular biology and bioengineering, discussed discoveries that drive the field of bioelectronic medicine forward at a recent three-day symposium. The Feinstein Institute for Medical Research, the Karolinska Institutet and its journal, the Journal of Internal Medicine, hosted “Bioelectronic Medicine: Technology Targeting Molecular Mechanisms,” which took place June 12-14 in Stockholm Sweden. “With discoveries announced, the pace of bioelectronic medicine is accelerating,” said Kevin J. Tracey, MD, president and CEO of the… read more

posted in: Press Releases

Elmezzi Scholar named public policy fellow of the American Association of Immunologists

Posted

MANHASSET, NY – Feinstein Institute for Medical Research Elmezzi Graduate School of Molecular Medicine Scholar Gavin H. Imperato, MD, has been named a Public Policy Fellow of the American Association of Immunologists (AAI) for 2018-2019. Dr. Imperato is a PhD candidate at the Elmezzi Graduate School where he studies the neuroscience of immunity. He works with researchers… read more

posted in: Press Releases

Chad Bouton discusses the future of Bioelectronic Medicine at the 2018 BIO International Convention

Posted

Professor Chad Bouton joins leaders in bioelectronic medicine to discuss how nerve and brain implants can revolutionize treatment of disease and debilitating injury during a panel discussion at the 2018 BIO International Convention. Click here to view event details.

posted in: Press Releases